211 related articles for article (PubMed ID: 18199544)
21. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
22. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
[TBL] [Abstract][Full Text] [Related]
23. The protein disulfide isomerase AGR2 is essential for production of intestinal mucus.
Park SW; Zhen G; Verhaeghe C; Nakagami Y; Nguyenvu LT; Barczak AJ; Killeen N; Erle DJ
Proc Natl Acad Sci U S A; 2009 Apr; 106(17):6950-5. PubMed ID: 19359471
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA LINC01207 silencing suppresses AGR2 expression to facilitate autophagy and apoptosis of pancreatic cancer cells by sponging miR-143-5p.
Liu C; Wang JO; Zhou WY; Chang XY; Zhang MM; Zhang Y; Yang XH
Mol Cell Endocrinol; 2019 Aug; 493():110424. PubMed ID: 30991076
[TBL] [Abstract][Full Text] [Related]
25. Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential.
Altorki N; Schwartz GK; Blundell M; Davis BM; Kelsen DP; Albino AP
Cancer; 1993 Aug; 72(3):649-57. PubMed ID: 8334620
[TBL] [Abstract][Full Text] [Related]
26. New anti-cancer chemicals Ertredin and its derivatives, regulate oxidative phosphorylation and glycolysis and suppress sphere formation in vitro and tumor growth in EGFRvIII-transformed cells.
Atsumi S; Nosaka C; Adachi H; Kimura T; Kobayashi Y; Takada H; Watanabe T; Ohba S; Inoue H; Kawada M; Shibasaki M; Shibuya M
BMC Cancer; 2016 Jul; 16():496. PubMed ID: 27431653
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis.
Tu MJ; Pan YZ; Qiu JX; Kim EJ; Yu AM
Oncotarget; 2016 Jul; 7(29):45547-45561. PubMed ID: 27322206
[TBL] [Abstract][Full Text] [Related]
28. MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway.
Mimori K; Shiraishi T; Mashino K; Sonoda H; Yamashita K; Yoshinaga K; Masuda T; Utsunomiya T; Alonso MA; Inoue H; Mori M
Oncogene; 2003 May; 22(22):3463-71. PubMed ID: 12776198
[TBL] [Abstract][Full Text] [Related]
29. Fas/APO-1 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma.
Hughes SJ; Nambu Y; Soldes OS; Hamstra D; Rehemtulla A; Iannettoni MD; Orringer MB; Beer DG
Cancer Res; 1997 Dec; 57(24):5571-8. PubMed ID: 9407969
[TBL] [Abstract][Full Text] [Related]
30. Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers.
Wang J; Day R; Dong Y; Weintraub SJ; Michel L
Mol Cancer Ther; 2008 Feb; 7(2):280-5. PubMed ID: 18281513
[TBL] [Abstract][Full Text] [Related]
31. The MUC4 membrane-bound mucin regulates esophageal cancer cell proliferation and migration properties: Implication for S100A4 protein.
Bruyère E; Jonckheere N; Frénois F; Mariette C; Van Seuningen I
Biochem Biophys Res Commun; 2011 Sep; 413(2):325-9. PubMed ID: 21889495
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.
Zhang J; Kou YB; Zhu JS; Chen WX; Li S
Int J Oncol; 2014 Apr; 44(4):1268-76. PubMed ID: 24481712
[TBL] [Abstract][Full Text] [Related]
33. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
[TBL] [Abstract][Full Text] [Related]
34. Anterior Gradient-2 monoclonal antibody inhibits lung cancer growth and metastasis by upregulating p53 pathway and without exerting any toxicological effects: A preclinical study.
Negi H; Merugu SB; Mangukiya HB; Li Z; Zhou B; Sehar Q; Kamle S; Yunus FU; Mashausi DS; Wu Z; Li D
Cancer Lett; 2019 May; 449():125-134. PubMed ID: 30685412
[TBL] [Abstract][Full Text] [Related]
35. Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer.
Blum AE; Venkitachalam S; Ravillah D; Chelluboyina AK; Kieber-Emmons AM; Ravi L; Kresak A; Chandar AK; Markowitz SD; Canto MI; Wang JS; Shaheen NJ; Guo Y; Shyr Y; Willis JE; Chak A; Varadan V; Guda K
Gastroenterology; 2019 May; 156(6):1761-1774. PubMed ID: 30768984
[TBL] [Abstract][Full Text] [Related]
36. RAD9A promotes metastatic phenotypes through transcriptional regulation of anterior gradient 2 (AGR2).
Broustas CG; Hopkins KM; Panigrahi SK; Wang L; Virk RK; Lieberman HB
Carcinogenesis; 2019 Mar; 40(1):164-172. PubMed ID: 30295739
[TBL] [Abstract][Full Text] [Related]
37. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
[TBL] [Abstract][Full Text] [Related]
38. NRAGE promotes cell proliferation by stabilizing PCNA in a ubiquitin-proteasome pathway in esophageal carcinomas.
Yang Q; Ou C; Liu M; Xiao W; Wen C; Sun F
Carcinogenesis; 2014 Jul; 35(7):1643-51. PubMed ID: 24710624
[TBL] [Abstract][Full Text] [Related]
39. Advanced Intestinal Cancers often Maintain a Multi-Ancestral Architecture.
Zahm CD; Szulczewski JM; Leystra AA; Paul Olson TJ; Clipson L; Albrecht DM; Middlebrooks M; Thliveris AT; Matkowskyj KA; Washington MK; Newton MA; Eliceiri KW; Halberg RB
PLoS One; 2016; 11(2):e0150170. PubMed ID: 26919712
[TBL] [Abstract][Full Text] [Related]
40. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
